Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Recombinant Human Interleukin-2 for Injection

Approval Number

国药准字S10980049

Company北京亚东生物制药（安国）有限公司

Registration Date

February 9, 2021

Drug Information

Generic Name

注射用人白介素-2

Trade Name

悦康仙

Dosage Form

注射剂

Strength

50万IU/支

Drug Type

生物制品

Registration Date

February 9, 2021

Company Information

Applicant Company

Company Name北京亚东生物制药（安国）有限公司

Company Address

安国市义丰大路1号

Manufacturing Company

Company Name深圳科兴生物工程有限公司

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy